EG16492A - Method of preparing of 6,7 - dihydro - 5,8 - dimethyl -9- fluro -1- oxo -1h,5h - benzo (ij) quinolizine -2- carboxylic acid and derivatives - Google Patents
Method of preparing of 6,7 - dihydro - 5,8 - dimethyl -9- fluro -1- oxo -1h,5h - benzo (ij) quinolizine -2- carboxylic acid and derivativesInfo
- Publication number
- EG16492A EG16492A EG70383A EG70383A EG16492A EG 16492 A EG16492 A EG 16492A EG 70383 A EG70383 A EG 70383A EG 70383 A EG70383 A EG 70383A EG 16492 A EG16492 A EG 16492A
- Authority
- EG
- Egypt
- Prior art keywords
- quinolizine
- benzo
- dihydro
- oxo
- dimethyl
- Prior art date
Links
- 150000001875 compounds Chemical class 0.000 abstract 4
- 239000002253 acid Substances 0.000 abstract 2
- -1 alkylaminoalkyl ester salts Chemical class 0.000 abstract 2
- 150000001263 acyl chlorides Chemical class 0.000 abstract 1
- 239000004599 antimicrobial Substances 0.000 abstract 1
- 230000000694 effects Effects 0.000 abstract 1
- 150000002148 esters Chemical class 0.000 abstract 1
- 239000000543 intermediate Substances 0.000 abstract 1
- 239000008194 pharmaceutical composition Substances 0.000 abstract 1
- 230000003389 potentiating effect Effects 0.000 abstract 1
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D471/00—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00
- C07D471/02—Heterocyclic compounds containing nitrogen atoms as the only ring hetero atoms in the condensed system, at least one ring being a six-membered ring with one nitrogen atom, not provided for by groups C07D451/00 - C07D463/00 in which the condensed system contains two hetero rings
- C07D471/04—Ortho-condensed systems
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D455/00—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/03—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine
- C07D455/04—Heterocyclic compounds containing quinolizine ring systems, e.g. emetine alkaloids, protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing quinolizine ring systems directly condensed with at least one six-membered carbocyclic ring, e.g. protoberberine; Alkylenedioxy derivatives of dibenzo [a, g] quinolizines, e.g. berberine containing a quinolizine ring system condensed with only one six-membered carbocyclic ring, e.g. julolidine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/04—Antibacterial agents
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/18—Halogen atoms or nitro radicals
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D215/00—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems
- C07D215/02—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom
- C07D215/16—Heterocyclic compounds containing quinoline or hydrogenated quinoline ring systems having no bond between the ring nitrogen atom and a non-ring member or having only hydrogen atoms or carbon atoms directly attached to the ring nitrogen atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D215/48—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- General Health & Medical Sciences (AREA)
- General Chemical & Material Sciences (AREA)
- Medicinal Chemistry (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- Oncology (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Animal Behavior & Ethology (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Public Health (AREA)
- Veterinary Medicine (AREA)
- Nitrogen Condensed Heterocyclic Rings (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
- Heterocyclic Carbon Compounds Containing A Hetero Ring Having Nitrogen And Oxygen As The Only Ring Hetero Atoms (AREA)
- Quinoline Compounds (AREA)
- Agricultural Chemicals And Associated Chemicals (AREA)
Applications Claiming Priority (1)
| Application Number | Priority Date | Filing Date | Title |
|---|---|---|---|
| US06/441,245 US4472405A (en) | 1982-11-12 | 1982-11-12 | Antimicrobial 6,7-dihydro-5,8-dimethyl-9 fluoro-1-oxo-1H, 5H-benzo (ij) quinolizine-2-carboxylic acid and derivatives |
Publications (1)
| Publication Number | Publication Date |
|---|---|
| EG16492A true EG16492A (en) | 1994-11-30 |
Family
ID=23752110
Family Applications (1)
| Application Number | Title | Priority Date | Filing Date |
|---|---|---|---|
| EG70383A EG16492A (en) | 1982-11-12 | 1983-11-12 | Method of preparing of 6,7 - dihydro - 5,8 - dimethyl -9- fluro -1- oxo -1h,5h - benzo (ij) quinolizine -2- carboxylic acid and derivatives |
Country Status (22)
| Country | Link |
|---|---|
| US (1) | US4472405A (ja) |
| EP (1) | EP0109284B1 (ja) |
| JP (1) | JPH0826017B2 (ja) |
| KR (1) | KR890000864B1 (ja) |
| AT (1) | ATE39926T1 (ja) |
| AU (1) | AU568319B2 (ja) |
| CA (2) | CA1254568A (ja) |
| CS (1) | CS390391A3 (ja) |
| DE (1) | DE3378912D1 (ja) |
| EG (1) | EG16492A (ja) |
| ES (1) | ES8504727A1 (ja) |
| FI (1) | FI73213C (ja) |
| GR (1) | GR79402B (ja) |
| IE (1) | IE56232B1 (ja) |
| IL (1) | IL70198A (ja) |
| IN (1) | IN161391B (ja) |
| MX (1) | MX7314E (ja) |
| NO (1) | NO160782C (ja) |
| NZ (1) | NZ206233A (ja) |
| OA (1) | OA07586A (ja) |
| PT (1) | PT77649B (ja) |
| ZA (1) | ZA838436B (ja) |
Families Citing this family (15)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| DE3519926A1 (de) * | 1985-06-04 | 1986-12-04 | Bayer Ag | Indolinderivate, verfahren zu ihrer herstellung und diese indolinderivate enthaltende kosmetische lichtschutzmittel |
| CA1302413C (en) * | 1986-01-22 | 1992-06-02 | Bruce E. Williams | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo- 1h,5h-benzo[ij]quinolizine-2-carboxylic acid |
| US4898945A (en) * | 1986-01-22 | 1990-02-06 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-5,8-dimethyl-9-fluoro-1-oxo-1H,5H-benzo[i,j]quinolizine-2-carboxylic acid |
| GB9827865D0 (en) * | 1998-12-18 | 1999-02-10 | Woodcock Fiona | Medicament |
| DE10312346A1 (de) * | 2003-03-20 | 2004-09-30 | Bayer Healthcare Ag | Kontrolliertes Freisetzungssystem |
| DE10351448A1 (de) | 2003-11-04 | 2005-06-09 | Bayer Healthcare Ag | Geschmackstoffhaltige Arzneimittelformulierungen mit verbesserten pharmazeutischen Eigenschaften |
| DE102005055385A1 (de) * | 2004-12-09 | 2006-06-14 | Bayer Healthcare Ag | Arzneimittel zur hygienischen Applikation im Ohr |
| DE102006010642A1 (de) * | 2006-03-08 | 2007-09-27 | Bayer Healthcare Aktiengesellschaft | Arzneimittelformulierungen, enthaltend Fluorchinolone |
| DE102006010643A1 (de) | 2006-03-08 | 2007-09-13 | Bayer Healthcare Aktiengesellschaft | Arzneimittel enthaltend Fluorchinolone |
| DE102007026550A1 (de) * | 2007-06-08 | 2008-12-11 | Bayer Healthcare Ag | Extrudate mit verbesserter Geschmacksmaskierung |
| DE102007055341A1 (de) | 2007-11-19 | 2009-05-20 | Bayer Animal Health Gmbh | Stabilisierung öliger Suspensionen enthaltend hydrophobe Kieselsäuren |
| AU2011315555B2 (en) | 2010-10-12 | 2016-03-10 | Elanco Animal Health Gmbh | Non-starch based soft chewables |
| US10543170B2 (en) | 2012-12-19 | 2020-01-28 | Bayer Animal Health Gmbh | Tablets with improved acceptance and good storage stability |
| MD4291C1 (ro) * | 2013-12-27 | 2015-02-28 | Государственный Медицинский И Фармацевтический Университет "Nicolae Testemitanu" Республики Молдова | Preparat medicamentos pentru tratamentul otitelor |
| CN114727622A (zh) * | 2019-09-06 | 2022-07-08 | 礼蓝美国公司 | 适口颗粒状兽用药组合物 |
Family Cites Families (6)
| Publication number | Priority date | Publication date | Assignee | Title |
|---|---|---|---|---|
| BE793524A (fr) * | 1971-12-30 | 1973-06-29 | Riker Laboratories Inc | Acides benzoquinolizine-carboxyliques et leurs derives |
| ZA728444B (en) * | 1971-12-30 | 1973-10-31 | Riker Laboratories Inc | Substituted benzo(ij)quinolizine-2-carboxylic acids and derivatives thereof |
| JPS5630964A (en) * | 1979-08-22 | 1981-03-28 | Kyorin Pharmaceut Co Ltd | Novel substituted quinolinecarboxylic acid and its preparation |
| JPS5655388A (en) | 1979-10-11 | 1981-05-15 | Otsuka Pharmaceut Co Ltd | Benzo ij quinolidine-2-carboxylic acid derivative, and its preparation |
| US4301289A (en) * | 1980-02-19 | 1981-11-17 | Minnesota Mining And Manufacturing Company | Process for 6,7-dihydro-9-fluoro-5-methyl-1-oxo-1H,5H-benzo(ij)quinolizine-2-carboxylic acid |
| JPS59155381A (ja) * | 1983-02-22 | 1984-09-04 | Kyorin Pharmaceut Co Ltd | ベンゾキノリジンカルボン酸誘導体及びその製造法 |
-
1982
- 1982-11-12 US US06/441,245 patent/US4472405A/en not_active Expired - Lifetime
-
1983
- 1983-10-27 CA CA000439826A patent/CA1254568A/en not_active Expired
- 1983-11-09 NO NO834093A patent/NO160782C/no unknown
- 1983-11-10 OA OA58156A patent/OA07586A/xx unknown
- 1983-11-10 ES ES527163A patent/ES8504727A1/es not_active Expired
- 1983-11-11 PT PT77649A patent/PT77649B/pt not_active IP Right Cessation
- 1983-11-11 ZA ZA838436A patent/ZA838436B/xx unknown
- 1983-11-11 NZ NZ206233A patent/NZ206233A/en unknown
- 1983-11-11 JP JP58212306A patent/JPH0826017B2/ja not_active Expired - Lifetime
- 1983-11-11 MX MX8310883U patent/MX7314E/es unknown
- 1983-11-11 AT AT83306908T patent/ATE39926T1/de not_active IP Right Cessation
- 1983-11-11 IN IN1382/CAL/83A patent/IN161391B/en unknown
- 1983-11-11 IL IL70198A patent/IL70198A/xx not_active IP Right Cessation
- 1983-11-11 EP EP83306908A patent/EP0109284B1/en not_active Expired
- 1983-11-11 DE DE8383306908T patent/DE3378912D1/de not_active Expired
- 1983-11-11 GR GR72947A patent/GR79402B/el unknown
- 1983-11-11 AU AU21181/83A patent/AU568319B2/en not_active Ceased
- 1983-11-11 FI FI834147A patent/FI73213C/fi not_active IP Right Cessation
- 1983-11-11 IE IE2639/83A patent/IE56232B1/en not_active IP Right Cessation
- 1983-11-12 EG EG70383A patent/EG16492A/xx active
- 1983-11-12 KR KR1019830005376A patent/KR890000864B1/ko not_active IP Right Cessation
-
1988
- 1988-08-05 CA CA000574069A patent/CA1280755C/en not_active Expired - Fee Related
-
1991
- 1991-12-19 CS CS913903A patent/CS390391A3/cs unknown
Also Published As
| Publication number | Publication date |
|---|---|
| ATE39926T1 (de) | 1989-01-15 |
| EP0109284B1 (en) | 1989-01-11 |
| FI834147A (fi) | 1984-05-13 |
| IE56232B1 (en) | 1991-05-22 |
| IL70198A0 (en) | 1984-02-29 |
| KR840006659A (ko) | 1984-12-01 |
| JPH0826017B2 (ja) | 1996-03-13 |
| JPS59112969A (ja) | 1984-06-29 |
| US4472405A (en) | 1984-09-18 |
| PT77649B (en) | 1986-03-19 |
| CA1280755C (en) | 1991-02-26 |
| NO834093L (no) | 1984-05-14 |
| IN161391B (ja) | 1987-11-28 |
| FI73213B (fi) | 1987-05-29 |
| NO160782C (no) | 1989-05-31 |
| PT77649A (en) | 1983-12-01 |
| CS390391A3 (en) | 1992-09-16 |
| MX7314E (es) | 1988-05-11 |
| CA1254568A (en) | 1989-05-23 |
| FI73213C (fi) | 1987-09-10 |
| DE3378912D1 (de) | 1989-02-16 |
| IL70198A (en) | 1988-11-15 |
| ZA838436B (en) | 1985-06-26 |
| NZ206233A (en) | 1986-10-08 |
| IE832639L (en) | 1984-05-12 |
| FI834147A0 (fi) | 1983-11-11 |
| KR890000864B1 (ko) | 1989-04-11 |
| OA07586A (fr) | 1985-03-31 |
| EP0109284A1 (en) | 1984-05-23 |
| ES527163A0 (es) | 1985-05-01 |
| ES8504727A1 (es) | 1985-05-01 |
| AU2118183A (en) | 1984-05-17 |
| NO160782B (no) | 1989-02-20 |
| GR79402B (ja) | 1984-10-22 |
| AU568319B2 (en) | 1987-12-24 |
Similar Documents
| Publication | Publication Date | Title |
|---|---|---|
| EG16492A (en) | Method of preparing of 6,7 - dihydro - 5,8 - dimethyl -9- fluro -1- oxo -1h,5h - benzo (ij) quinolizine -2- carboxylic acid and derivatives | |
| HUT45520A (en) | Process for producing new quinoline derivatives and pharmaceutics comprising these compounds as active ingredient | |
| PT80773A (en) | Process for the preparation of substituted benzoate ester prodrug derivatives of 3-hydroxymorfinans intermediates thereto and of pharmaceutical compositions containing the same | |
| HUT45515A (en) | Process for producing benzoxazine and benzthiazine acetic acid derivatives and pharmaceutics comprising these compounds as active ingredient | |
| ES8702405A1 (es) | Procedimiento para la obtencion de acidos benzo(ij) quinolizina-2-carboxilicos y sus derivados | |
| DK159778A (da) | Forbindelsesstik til flade traadkabler | |
| NO301372B1 (no) | Fremgangsmåte for fremstilling av et farmasöytisk tålbart salt av klavulansyre | |
| NO175369C (no) | Analogifremgangsmåte for fremstilling av den terapeutisk aktive forbindelse (S)-7-(3-amino-1,4-dihydro-4-okso-1,8-naftyridin-3-karboksylsyre, en in vivo lett spaltbar lavere alkylester eller et farmasöytisk akseptabelt salt | |
| JPS57108066A (en) | 4-substituted-2-oxoazetidine derivative and its preparation | |
| ES2001852A6 (es) | Procedimiento para preparar un derivado de acido quinolocarboxilico | |
| AR242203A1 (es) | Procedimiento de preparacion de derivados del acido carbamico. | |
| SE8301687L (sv) | 8-cyano-6,7-dihydro-5-metyl-1-oxo-1h-,5h-benso(ij)kinolizin-2-karboxylsyror och forfarande for framstellning derav | |
| YU104986A (en) | Process for obtaining penem derivatives | |
| FR2331547A1 (fr) | Procede de preparation d'un fluorure d'acyle fluore presentant un groupement ester | |
| DK550183A (da) | 6,7-dihydro-5,8-dimethyl-9-fluor-1-oxo-1h,5h-benzo/ij/-quinolizin-2-carboxylsyre, fremgangsmaade til fremstilling deraf og mellemprodukter til brug ved udoevelse af fremgangsmaaden | |
| GB2102812B (en) | Therapeutically active compounds from species of rubia synthetic derivatives thereof, methods for the production thereof and pharmaceutical compositions comprising the same | |
| IT1101667B (it) | Esteri 3-fenossi-alfa-vinil-benzilici di acidi vinil-ciclopropan-carbossilici, procedimento per la loro preparatione e loro impiego per combattere organismi nocivi | |
| JPS57146775A (en) | 1,8-naphthyridine derivative and its salt | |
| DE3560363D1 (en) | Process for the preparation of carbamic acid esters derivatives | |
| PH20548A (en) | Novel penem compounds,pharmaceutical compositions containing them and method of using said compounds | |
| JPS57183737A (en) | Use of phenylaliphatic carboxylic acid derivative as drug | |
| JPS5772981A (en) | 1,8-naphthyridine derivative and its salt | |
| HUT60736A (en) | Process for producing derivatives of 3-l-(5-thioxo-l-prolyl)-thiazolidine-4-carboxylic acid and pharmaceutical compositions comprising same as active ingredient | |
| LV5479A3 (lv) | Hinolina atvasinajumu vai to farmaceitiski pienemamu esteru vai farmaceitiski pienemamu skabes aditivo salu iegusanas metode | |
| HRP921328B1 (en) | Process for the preparation of cyclopropanecarboxyle acid ester derivatives |